Cold-cough

Commercial

Portfolio-7447-for-WEB

NCE Pipeline

Discovery-7447-for-WEB

Research

Latest Report and Accounts 

Vernalis plc - AR 30-06-2017 - COVER PAGE FOR WEBSITE Page 001

30 June, 2017 Results

Download our latest report...

Archive

Latest Presentation

ceo12 September, 2017

Our latest presentation is available to view from here...

Archive

Share Price

Share price:  12.75p
Change:  0.50 (4.17%)
As at:  13 December 2017 15:35:25
Volume:  292,895
LSE ID:  VER

Share price details

Latest News

Vernalis plc enters into research collaboration with Daiichi Sankyo

Vernalis plc (LSE: VER) announced today that it has entered into a drug discovery collaboration with Daiichi Sankyo Company, Limited utilizing Vernalis' fragment and structure-based drug discovery platform against undisclosed oncology targets. 

Read more ...

At a glance

More information on Vernalis and its pipeline ...

FactsheetNov14 Company fact sheet

Comm thumbnail Explore the pipeline ...

Contact Vernalis

T: 0118 938 0000
F: 0118 938 0001

Contact information
Maps and directions
Contact form

To report SUSPECTED ADVERSE REACTIONS, contact Vernalis Therapeutics, Inc. at 1-855-705-9546 and drugsafety@propharmagroup.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch